The Agenda for Continuing Medical Education — Limiting Industry's Influence

Abstract

Drug and device manufacturers provide more than half the funding for continuing medical education (CME) and indirectly influence its content. The authors describe potential strategies to safeguard CME from bias and to improve its value to clinicians.